COVID-19 has had a huge impact on societies and businesses across the globe and Glass Technology Services (GTS) has worked hard over the past three months to minimise any delays on essential product lines.
Pharmaceutical companies play a highly important role during the pandemic, whether that’s their role in the diagnosis and treatment of the infection, work to prevent the transmission through the development of a vaccine or the continuation of the everyday medications used worldwide.
The team have been pleased to support new and existing pharmaceutical customers during this challenging time with pharmacopeial durability analysis, delamination studies or technical consultancy – prioritising customers to ensure efficient turnaround times whilst operating at safe staffing levels.
Commenting, Operations and Commercial Director Gareth Jones said, “We recognise the important role our pharmaceutical customers play during this time and it was important we could continue to offer the continuation of service they vitally needed.
“We were able to quickly adapt to put safe working parameters in place to ensure the health and safety of our technical staff working within our laboratories which enabled us to operate a skeleton staff prioritising the essential product lines of pharmaceuticals and food and drink.
“I’m delighted we’ve been able to continue operating without a break in service for existing and new customers – offering quick turnaround times to those who need them.”
Glass Technology Services are specialists in the field of analysis, inspection, and performance testing for companies throughout the pharmaceutical supply chain, employing industry leading experts in the latest glass technologies, chemical durability, migration, and pharmaceutical packaging.